Compound 14a, a PD derivative, exhibited significant neuroprotective properties, including apoptosis inhibition, prevention of tau hyperphosphorylation, modulation of beta‐amyloid, and reduction of ROS [25]. This evidence concerns the gene MAPT and Parkinson disease.